Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 8;15(2):259.
doi: 10.3390/life15020259.

Collagenase Clostridium Histolyticum Versus Percutaneous Needle Fasciotomy for Dupuytren's Disease: A Systematic Review and Meta-Analysis

Ishith Seth  1   2 , Vicki McClure  2 , Bryan Lim  2 , Roberto Cuomo  3 , Richard J Ross  1   2 , Warren M Rozen  1   2
Affiliations
Review

Collagenase Clostridium Histolyticum Versus Percutaneous Needle Fasciotomy for Dupuytren's Disease: A Systematic Review and Meta-Analysis

Ishith Seth et al. Life (Basel). .

Abstract

Minimally invasive treatments for Dupuytren's disease (DD), such as percutaneous needle fasciotomy (PNF) and collagenase clostridium histolyticum (CCH), have become alternatives to open surgeries. This meta-analysis compared these treatments in terms of complications, patient satisfaction, clinical outcomes, and recurrence. Relevant studies up to June 2024 were identified through major databases, following PRISMA guidelines, and the study was registered on PROSPERO. Statistical analysis using Review Manager 5.4 found PNF had lower post-operative rates of oedema (RR = 0.15, 95% CI [0.09, 0.27], p < 0.00001), lymphadenopathy (RR = 0.09, 95% CI [0.02, 0.38], p = 0.0010), and pruritus (RR = 0.1, 95% CI [0.01, 0.73], p = 0.02) compared to CCH. However, there were no significant differences in skin tears, recurrence, reintervention, extension deficit, or residual flexion at metacarpal and proximal interphalangeal joints (p > 0.05). Patient-reported outcomes, including QuickDASH and URAM scores, also showed no significant differences. Eleven studies involving 1443 patients were analysed, and most were at a low-to-moderate risk of bias, as assessed using the Cochrane or Newcastle-Ottawa tools. While PNF showed fewer minor complications, overall clinical and patient-reported outcomes were comparable between the treatments. These findings highlight the need to tailor treatment choices to patient preferences and clinical context.

Keywords: CCH; Dupuytren’s contracture; PNF; collagenase; percutaneous fasciotomy.

PubMed Disclaimer

Conflict of interest statement

The authors do not have any potential conflicts of interest with respect to this manuscript.

Figures

Figure 1
Figure 1
PRISMA flow diagram of selected studies.
Figure 2
Figure 2
Summary of the quality assessment of the included randomised controlled trials. Green represents low risk of bias, yellow represents moderate risk of bias and red represents high risk of bias.
Figure 3
Figure 3
Forest plot comparing edema rate between collagenase clostridium histolyticum and percutaneous needle fasciotomy.
Figure 4
Figure 4
Forest plot comparing lymphadenopathy rate between collagenase clostridium histolyticum and percutaneous needle fasciotomy.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Lanting R., Broekstra D.C., Werker P.M.N., van den Heuvel E.R. A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of Western countries. Plast. Reconstr. Surg. 2014;133:593–603. doi: 10.1097/01.prs.0000438455.37604.0f. - DOI - PMC - PubMed
    1. Carr L., Michelotti B., Brgoch M., Hauck R., Ingraham J. Dupuytren Disease Management Trends: A Survey of Hand Surgeons. Hand. 2020;15:97–102. doi: 10.1177/1558944718787281. - DOI - PMC - PubMed
    1. Lermusiaux J., Debeyre N. L’Actualité Rhumatologique 1979 Présentée Aux Praticien. Expansion Scientifique Francaise; Paris, France: 1980.
    1. Byström M., Ibsen Sörensen A., Samuelsson K., Fridén J.O., Strömberg J. Five-Year Results of a Randomized, Controlled Trial of Collagenase Treatment Compared With Needle Fasciotomy for Dupuytren Contracture. J. Hand Surg. Am. 2022;47:211–217. doi: 10.1016/j.jhsa.2021.11.019. - DOI - PubMed
    1. Scherman P., Jenmalm P., Dahlin L.B. One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren’s contracture: A two-centre prospective randomized clinical trial. J. Hand Surg. Eur. Vol. 2016;41:577–582. doi: 10.1177/1753193415617385. - DOI - PubMed

LinkOut - more resources